providing effective symptom relief and substantial cost savings compared to oral metoclopramide. Despite safety concerns surrounding domperidone, which has never been approved in the U.S ...

FDA posts update as mechanism to obtain unapproved Domperidone expected to lose supply in early 2025Gimoti remains only approved drug shown to ...

As the sole FDA-approved nasal spray treatment for acute and recurrent diabetic gastroparesis in adults, GIMOTI® (metoclopramide ... an alternative source [of domperidone] have been unsuccessful.

(link) Domperidone, while used internationally ... re-educate themselves about the options that are available, like oral metoclopramide and GIMOTI, and for all stakeholders to reduce the barriers ...